Haystack Oncology

Baltimore, Maryland, United States

Cancer Diagnostics Molecular Diagnostics Biomarker Monitoring

Haystack Oncology represents the culmination of over 20 years of collaboration to advance technical and clinical development in liquid biopsy technologies by cancer genomics pioneers at Johns Hopkins School of Medicine. The company, a wholly owned subsidiary of Quest Diagnostics, developed Haystack MRD™, a next generation tumor-informed approach for the measurement of minimal residual disease. Haystack MRD uses an error-corrected ctDNA technology to detect down to one ctDNA molecule in a million normal DNA molecules. Haystack Oncology works with biopharmaceutical companies to accelerate and better inform clinical development programs and advance important therapeutics to global markets, from early phase clinical development to companion diagnostics.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Haystack Oncology on @MedStartr Today #EarlyCancerDetection #CancerDetectionBreastLungCervical #CancerOncology #Cancer #Diagnostics #MolecularDiagnostics #BiomarkerMonitoring #MedMo #MedStartrVentures

https://www.medstartr.ai/s/S1F9Teq8SA0

Get Involved in Haystack Oncology

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: haystackmrd.com/

Disease Areas

Early Cancer Detection Cancer Detection (Breast, Lung, Cervical)Cancer & Oncology

Technologies

Liquid BiopsyMolecular DiagnosticsDiagnosticsSequencing Technology

🌐Website

What do you think of Haystack Oncology?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.